OKE
61
2
AMT
30
2
SRE
37
9
AEP
45
5
EQR
33
6
AIZ
61
5
PNC
48
6
AON
25
4
PEP
33
4
AMAT
33
3
LNC
28
3
AES
47
4
MTB
38
4
XOM
33
3
HES
49
2
JNPR
59
3
CAT
47
3
AMGN
42
14
BDX
59
3
PCG
59
9
OKE
61
2
AMT
30
2
SRE
37
9
AEP
45
5
EQR
33
6
AIZ
61
5
PNC
48
6
AON
25
4
PEP
33
4
AMAT
33
3
LNC
28
3
AES
47
4
MTB
38
4
XOM
33
3
HES
49
2
JNPR
59
3
CAT
47
3
AMGN
42
14
BDX
59
3
PCG
59
9
Financhill
Back

ANI Pharmaceuticals 10K Form

Sell
21

ANIP
ANI Pharmaceuticals

Last Price:
$53.38
Seasonality Move:
15.88%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-10 10Q ANIP/ANI Pharmaceuticals Quarterly
2023-11-08 10Q ANIP/ANI Pharmaceuticals Quarterly
2023-08-09 10Q ANIP/ANI Pharmaceuticals Quarterly
2023-05-08 10Q ANIP/ANI Pharmaceuticals Quarterly
2022-11-09 10Q ANIP/ANI Pharmaceuticals Quarterly
2022-08-08 10Q ANIP/ANI Pharmaceuticals Quarterly

Receive ANIP News And Ratings

See the #1 stock for the next 7 days that we like better than ANIP

ANIP Financial Statistics

Sales & Book Value

Annual Sales: $486.8M
Cash Flow: $7M
Price / Cash Flow: 14.04
Annual Sales: $19.27
Price / Book: 2.76

Profitability

EPS (TTM): -0.57000
Net Income (TTM): $-7.1M
Gross Margin: $305.3M
Return on Equity: -1.54%
Return on Assets: -0.72%

ANI Pharmaceuticals Earnings Forecast

Key ANI Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 16 years for ANIP is 62.71%.
  • The Selling, General & Administrative Expenses for ANIP have been equal to 33.22% of Gross Profit Margin.
  • The Research & Development expenses have been 7.04% of Revenue.
  • The Interest Expense is 143.46% of Operating Income.
  • The Net Earning history of ANIP is 3.86% of Total Revenues.
  • Per Share Earnings over the last 26 years have been positive in 12 years.

ANI Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: ANIP
CUSIP: 00182C
Website: anipharmaceuticals.com

Debt

Debt-to-Equity Ratio: 1.45
Current Ratio: 2.74
Quick Ratio: 1.84

Price-to-Earnings

Trailing P/E Ratio: 62.81
Forward P/E Ratio: 9.77

ANIP Technical Analysis vs Fundamental Analysis

Sell
21
ANI Pharmaceuticals (ANIP) is a Sell

Is ANI Pharmaceuticals a Buy or a Sell?